Efficacy of Traditional Chinese Medicine Combined with Selective Serotonin Reuptake Inhibitors on the Treatment for Parkinson's Disease with Depression: A Systematic Review and Meta-Analysis.
Depression
/ drug therapy
Drug Therapy, Combination
Drugs, Chinese Herbal
/ administration & dosage
Female
Humans
Male
Medicine, Chinese Traditional
Parkinson Disease
/ complications
Phytotherapy
Plant Extracts
/ administration & dosage
Selective Serotonin Reuptake Inhibitors
/ administration & dosage
Treatment Outcome
Depression
Herbal Formula
Meta-Analysis
Parkinson’s Disease
Selective Serotonin Reuptake Inhibitor
Systematic Review
Traditional Chinese Medicine
Journal
The American journal of Chinese medicine
ISSN: 1793-6853
Titre abrégé: Am J Chin Med
Pays: Singapore
ID NLM: 7901431
Informations de publication
Date de publication:
2021
2021
Historique:
pubmed:
5
3
2021
medline:
15
9
2021
entrez:
4
3
2021
Statut:
ppublish
Résumé
Depression is a common neuropsychiatric symptom of Parkinson's disease (PD), resulting in a lower quality of life and cognitive impairment in PD patients. Traditional Chinese medicine (TCM) formulas have been widely used in neurodegenerative disease and neuropsychic disorders to improve life quality of patients in ethnomedicine. TCM formulas combined with selective serotonin reuptake inhibitors (SSRIs) also have a positive effect on depressed PD compared with SSRIs as reported by several clinical studies. However, the results are discordant and failed to be conclusive. We aim to evaluate the efficacy of TCM formulas combined with SSRIs for depressed PD in this systematic review. We searched literatures from PubMed, Web of Science, Medline, Embase, Google Scholar, Chinese National Knowledge Infrastructure, Wanfang Database, and VIP Information Database before July 2020. We included randomized controlled trials investigating the efficacy of TCM formulas combined with SSRIs on depressed PD patients. This analysis was according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. Eleven randomized clinical trials involving 861 subjects were enrolled in this analysis. The overall results showed that TCM formulas combined with SSRIs significantly improved the depression score [weighted mean difference (WMD): -4.920, 95% confidence interval (CI): (-5.999, -3.840); [Formula: see text]¡ 0.001] and had a statistical significance on Unified Parkinson's Disease Rating Scale II score [WMD: -1.209, 95% CI: (-1.561, -0.857); [Formula: see text] < 0.001]. Furthermore, we observed that Chai-Hu-Shu-Gan Powder combined with SSRIs had a significant improvement on the depressive symptom in PD compared to the SSRIs alone [WMD: -5.390, 95% CI: (-7.66, -3.11); [Formula: see text] < 0.001]. No severe side events were reported in these included trials. This systematic review provided the evidences that TCM formulas combined with SSRIs might be helpful and safe in the treatment of depression of PD, including Chai-Hu-Shu-Gan Powder. Also, more randomized double-blinded trials with reliable design are required in the future.
Identifiants
pubmed: 33657988
doi: 10.1142/S0192415X21500282
doi:
Substances chimiques
Drugs, Chinese Herbal
0
Plant Extracts
0
Serotonin Uptake Inhibitors
0
chaihu-shugan-san
0
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM